European journal of heart failure
-
Eur. J. Heart Fail. · Nov 2006
Randomized Controlled TrialCardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
Levosimendan is a new calcium sensitizer with positive inotropic properties. Cardiac power output (CPO) has been shown to be instrumental in the diagnosis of cardiogenic shock (CS) and is an important determinant of outcomes. ⋯ The primary objective of our study was achieved better by the end of the 24 h infusion of levosimendan than by dobutamine.